Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-02-25 @ 7:02 PM
Study NCT ID:
NCT02101268
Status:
COMPLETED
Last Update Posted:
2023-05-23
First Post:
2014-03-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF
Sponsor:
Sierra Oncology LLC - a GSK company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GS-US-352-1214
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None